Deerfield Management Company, L.p. (series C) Buys Nuvalent Inc, Sema4 Holdings Corp, Neurocrine Biosciences Inc, Sells Zimmer Biomet Holdings Inc, , Quidel Corp

• New Purchases: NUVL, SMFR, GKOS, VINC, MAAC, ERAS, LPTX, DALS, RXST, TYRA, DH, MTAC, REVH, SNRH, HLTH, NYXH, IGNY, OHPA, IRTC, TALK,
• Added Positions: NBIX, AERI, DAWN, AHCO, VIVO, BKD, CYTK, PHVS, KURA, LUNG, BCAB, ORGO, FATE, ATEC, INZY, SPRB, PTGX, CVRX,
• Reduced Positions: BCRX, AFIB, DCPH, HOWL, AVAH, ITMR, PCRX, WVE, XLRN, BPMC, SILK, ISEE, APR, SWTX, BDTX, GHRS, MIRM, BDSI,
• Sold Out: ZBH, CNST, QDEL, GLPG, RETA, OMI, PBYI, ARDX, FOLD, XERS, BHG, MAACU, STXS, JANX, DYN, BLUE, CMRX, IMCR, RNA, BVS, CNVY, AGL, LFST, REVHU, ADVM, MTACU, SNRHU, CMIIU, GLUE, IGNYU, INSM, CHFW.U, OHPAU, XENT, BMEA, ACHL, LUMO,

For the details of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s stock buys and sells, go to https://www.gurufocus.com/guru/deerfield+management+company%2C+l.p.+%28series+c%29/current-portfolio/portfolio

1. Nuvalent Inc (NUVL) - 19,341,024 shares, 12.13% of the total portfolio. New Position
2. Viatris Inc (VTRS) - 18,824,000 shares, 7.09% of the total portfolio.
3. AdaptHealth Corp (AHCO) - 8,103,792 shares, 5.25% of the total portfolio. Shares added by 10.20%
4. CareMax Inc (CMAX) - 16,778,750 shares, 4.51% of the total portfolio.
5. Neurocrine Biosciences Inc (NBIX) - 1,142,415 shares, 3.05% of the total portfolio. Shares added by 57.57%

Deerfield Management Company, L.p. (series C) initiated holding in Nuvalent Inc. The purchase prices were between $18.25 and $38.35, with an estimated average price of $29.21. The stock is now traded at around $27.500000. The impact to a portfolio due to this purchase was 12.13%. The holding were 19,341,024 shares as of 2021-09-30.

Deerfield Management Company, L.p. (series C) initiated holding in Sema4 Holdings Corp. The purchase prices were between $0 and $12.25, with an estimated average price of $9.55. The stock is now traded at around $7.290000. The impact to a portfolio due to this purchase was 2.92%. The holding were 13,848,488 shares as of 2021-09-30.

Deerfield Management Company, L.p. (series C) initiated holding in Glaukos Corp. The purchase prices were between $47.43 and $84.23, with an estimated average price of $55.92. The stock is now traded at around $50.110000. The impact to a portfolio due to this purchase was 0.83%. The holding were 619,000 shares as of 2021-09-30.

Deerfield Management Company, L.p. (series C) initiated holding in Vincerx Pharma Inc. The purchase prices were between $11.6 and $17.39, with an estimated average price of $14.62. The stock is now traded at around $12.700000. The impact to a portfolio due to this purchase was 0.62%. The holding were 1,379,310 shares as of 2021-09-30.

Deerfield Management Company, L.p. (series C) initiated holding in Montes Archimedes Acquisition Corp. The purchase prices were between $9.35 and $10.41, with an estimated average price of $9.93. The stock is now traded at around $9.350000. The impact to a portfolio due to this purchase was 0.52%. The holding were 2,000,000 shares as of 2021-09-30.

Deerfield Management Company, L.p. (series C) initiated holding in Erasca Inc. The purchase prices were between $17.43 and $24.34, with an estimated average price of $20.69. The stock is now traded at around $19.550000. The impact to a portfolio due to this purchase was 0.46%. The holding were 786,660 shares as of 2021-09-30.

Deerfield Management Company, L.p. (series C) added to a holding in Neurocrine Biosciences Inc by 57.57%. The purchase prices were between $86.18 and $99.03, with an estimated average price of $94.54. The stock is now traded at around $88.270000. The impact to a portfolio due to this purchase was 1.11%. The holding were 1,142,415 shares as of 2021-09-30.

Deerfield Management Company, L.p. (series C) added to a holding in Aerie Pharmaceuticals Inc by 260.44%. The purchase prices were between $11.32 and $16.63, with an estimated average price of $14.64. The stock is now traded at around $11.570000. The impact to a portfolio due to this purchase was 0.68%. The holding were 2,977,020 shares as of 2021-09-30.

Deerfield Management Company, L.p. (series C) added to a holding in Day One Biopharmaceuticals Inc by 108.89%. The purchase prices were between $20 and $27.92, with an estimated average price of $24. The stock is now traded at around $21.380000. The impact to a portfolio due to this purchase was 0.59%. The holding were 1,710,730 shares as of 2021-09-30.

Deerfield Management Company, L.p. (series C) added to a holding in Meridian Bioscience Inc by 44.85%. The purchase prices were between $17.35 and $22.5, with an estimated average price of $19.97. The stock is now traded at around $20.340000. The impact to a portfolio due to this purchase was 0.34%. The holding were 2,063,083 shares as of 2021-09-30.

Deerfield Management Company, L.p. (series C) added to a holding in Brookdale Senior Living Inc by 59.27%. The purchase prices were between $5.87 and $8.59, with an estimated average price of $7.15. The stock is now traded at around $6.920000. The impact to a portfolio due to this purchase was 0.34%. The holding were 5,252,800 shares as of 2021-09-30.

Deerfield Management Company, L.p. (series C) added to a holding in Cytokinetics Inc by 24.12%. The purchase prices were between $18.54 and $35.74, with an estimated average price of $29.35. The stock is now traded at around $39.240000. The impact to a portfolio due to this purchase was 0.3%. The holding were 1,536,758 shares as of 2021-09-30.

Deerfield Management Company, L.p. (series C) sold out a holding in Zimmer Biomet Holdings Inc. The sale prices were between $140.44 and $163.52, with an estimated average price of $151.62.

Deerfield Management Company, L.p. (series C) sold out a holding in . The sale prices were between $33.9 and $33.99, with an estimated average price of $33.95.

Deerfield Management Company, L.p. (series C) sold out a holding in Quidel Corp. The sale prices were between $114.31 and $157.32, with an estimated average price of $134.41.

Deerfield Management Company, L.p. (series C) sold out a holding in Galapagos NV. The sale prices were between $52.17 and $70.2, with an estimated average price of $59.52.

Deerfield Management Company, L.p. (series C) sold out a holding in Reata Pharmaceuticals Inc. The sale prices were between $100 and $143.02, with an estimated average price of $117.47.

Deerfield Management Company, L.p. (series C) sold out a holding in Owens & Minor Inc. The sale prices were between $30.87 and $47.58, with an estimated average price of $39.39.